A minimally invasive technique can successfully stop recurrent nosebleeds in patients who are prone to them, according to a radiologist's study published in the Journal of NeuroInterventional Surgery.
A minimally invasive technique can successfully stop recurrent nosebleeds in patients who are prone to them, according to a radiologist's study published in the Journal of NeuroInterventional Surgery.
Nosebleeds can be particularly troubling for patients who have had nasal surgery or are taking blood thinners, aspirin, ibuprofen, or blood pressure drugs. In around 6% of cases, recurrent nosebleeds require nasal packing, heat cauterization, or invasive surgery to curb recurrence.
After endovascular embolization using platinum fiber coils, 19 of 20 patients had no further rebleeding, and only one patient had transient facial pain (J NeuroIntervent Surg 2010;2:171-175).
The technique uses a fine guidewire or catheter to insert detachable platinum coils. They expand into a predetermined shape to slow or block the flow of blood.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 2nd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 2nd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 2nd 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.